Indivior Pharmaceuticals IncINDV

$38.30+0.37 (+0.98%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$5B
Mid-cap
+86%
2021 — today
10-Year Price
+117%
2016 — today
52-Week Range
$13.69$40.61
Current $38.30· 91%

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.

Valuation in context

P/E ratio
19.3
Around average
Around the 10-year average
P/B ratio
-34.3
N/A
Not meaningful — company is unprofitable
EV / EBITDA
15.0
Above average
Pricier than usual over the last 10 years
FCF Yield
-3.7%
Below average
Below the 10-year average
Free · No credit card needed

Get alerted when INDV is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.